КраткосрочноСреднесрочноДолгосрочноСигналы

Nurix Therapeutics Inc [NRIX]

Биржа: NASDAQ
Сектор: Healthcare
Отрасль: Biotechnology
Последнее обновление 12 Jun 2026 @ 16:00 (Exchange is closed for the weekend)
Последняя: $16.95 -0.18%
0.82 (↑)
GaG Algo Score™
v1.0
Короткий
0.82 (↑)
Средний
2.50 (↑)
Длинный
2.08
КУПИТЬ
71.43%
доходность 44.31%
ПРОДАТЬ
32.00%
доходность 46.81%

Статистика

Объем сегодня 2.56M
Средний объем 1.68M
Капитализация 1.47B
EPS $-0.790 (Q1 | 2026-04-08)
Следующая дата отчетности ($-0.730) 2026-07-09
P/E -5.35 (Сектор) 26.21 (Отрасль) 17.28
ATR14 $1.256 (7.41%)
Возможный дневной размах $16.32 - $17.58 (7.70%)

Уровни поддержки и сопротивления

Линия

Pivot-данные

Статистика pivot
Метрика Среднее Медиана Ст. откл.
Рост % 26.45% 18.94% 23.53%
Падение % -13.21% -12.96% 4.79%
Длительность 16.5d 16d 8.5d
Всего найдено pivot 16
Фазы роста/падения 15 (8 Рост / 7 Падение)
Последний pivot Top @ $17.76 на 2026-05-29
Изменение с последнего pivot $-0.81 (-4.56%)
Прогноз следующего pivot Последняя: $16.95
Ожидаемый следующий тип Bottom
Прогноз цены (средн.) $15.41
Прогноз цены (медиана) $15.46
Прогноз диапазона цены (~68%) $14.56 - $16.26
Изменение к средней цели $-1.54 (-9.06%)
Прогноз даты (средн.) 2026-06-14
Прогноз диапазона дат (~68%) 2026-06-06 - 2026-06-23
Основа Based on 7 historical losses (Avg: -13.21%, Median: -12.96%, StdDev of Abs: 4.79%) and duration (Avg: 16.5 days, StdDev: 8.5 days)
Примечание Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Slight loss for Nurix Therapeutics Inc.

Nurix Therapeutics Inc (NRIX) stock price edged down slightly on Friday after the stock fell $-0.0300 (-0.18%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. Yesterday's trading volume was 2.56M shares, worth about $43.44M. This represents 1.47M shares less than the day before. Volume was below the 10-day average of 4.19M shares.

Nurix Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Nurix Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $17.00. approximately $0.0500 (0.29%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -

Nurix Therapeutics Inc Evaluation

  • Короткий оценка: 0.82
  • Средний оценка: 2.50
  • Длинный оценка: 2.08